Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) operable breast cancer (BC) Meeting Abstract
| Authors: | Moore, H. M.; Boni, V.; Bellet, M.; De Las Heras, B. B.; Cortés, M. G.; Oakman, C.; Schmid, P.; Trinh, X. B.; Wheatley, D.; Jhaveri, K. L.; Kabos, P.; Lim, E.; Velu, T.; Metcalfe, C.; Gates, M. R.; Chang, C. W.; Bond, J.; Goldstein, L. D.; Lauchle, J. O.; Bardia, A. |
| Abstract Title: | Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) operable breast cancer (BC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120600087 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.577 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 577 -- Source: Wos |
